NHS must accelerate use of weight-loss jabs, say obesity experts

New research finds Wegovy can reduce risk of heart attack, early death and stroke within three months of treatment

The NHS must accelerate its use of weight loss jabs, experts have said, as society enters a “golden age” of such medications.

Obesity is linked to numerous long-term conditions including cancer, heart disease, dementia and diabetes, putting a huge strain on the NHS.